Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Holderbaum

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Arthritis and Rheumatism|January 27, 1999
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutationJ F Bleasel, A R Poole, D Heinegård, et al.
The Journal of Rheumatology|February 1, 1995
Type II procollagen gene (COL2A1) mutation in exon 11 associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritisJ F Bleasel, A Bisagni-Faure, D Holderbaum, et al.
Human Mutation|August 26, 1998
Five families with arginine 519-cysteine mutation in COL2A1: evidence for three distinct foundersJ F Bleasel, D Holderbaum, V Brancolini, et al.
Annals of the New York Academy of Sciences|June 8, 1996
Arg519-Cys mutation in COL2A1: evidence for multiple foundersJ F Bleasel, D Holderbaum, V Brancolini, et al.
Arthritis and Rheumatism|February 1, 1994
Clinical correlations of osteoarthritis associated with a single-base mutation (arginine519 to cysteine) in type II procollagen gene. A newly defined pathogenesisY L Pun, R W Moskowitz, S Lie, et al.
Nature Genetics|September 2, 1999
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasiaJ R Hurvitz, W M Suwairi, W Van Hul, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Arthritis and Rheumatism|January 27, 1999
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutationJ F Bleasel, A R Poole, D Heinegård, et al.
The Journal of Rheumatology|February 1, 1995
Type II procollagen gene (COL2A1) mutation in exon 11 associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritisJ F Bleasel, A Bisagni-Faure, D Holderbaum, et al.
Human Mutation|August 26, 1998
Five families with arginine 519-cysteine mutation in COL2A1: evidence for three distinct foundersJ F Bleasel, D Holderbaum, V Brancolini, et al.
Annals of the New York Academy of Sciences|June 8, 1996
Arg519-Cys mutation in COL2A1: evidence for multiple foundersJ F Bleasel, D Holderbaum, V Brancolini, et al.
Arthritis and Rheumatism|February 1, 1994
Clinical correlations of osteoarthritis associated with a single-base mutation (arginine519 to cysteine) in type II procollagen gene. A newly defined pathogenesisY L Pun, R W Moskowitz, S Lie, et al.
Nature Genetics|September 2, 1999
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasiaJ R Hurvitz, W M Suwairi, W Van Hul, et al.
Pageof 3